Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
01/21/2021 01/22/2021 01/25/2021 01/26/2021 01/27/2021 Date
360.7(c) 356.6(c) 375.9(c) 375(c) 376.6(c) Last
440 405 341 650 805 136 940 626 771 414 Volume
+0.56% -1.14% +5.41% -0.24% +0.43% Change
More quotes
Financials
Sales 2020 14 097 M 2 295 M 2 295 M
Net income 2020 2 868 M 467 M 467 M
Net Debt 2020 4 292 M 699 M 699 M
P/E ratio 2020 36,9x
Yield 2020 1,45%
Sales 2021 14 545 M 2 368 M 2 368 M
Net income 2021 3 000 M 489 M 489 M
Net Debt 2021 4 813 M 784 M 784 M
P/E ratio 2021 34,8x
Yield 2021 1,53%
Capitalization 106 B 17 171 M 17 185 M
EV / Sales 2020 7,79x
EV / Sales 2021 7,59x
Nbr of Employees 6 180
Free-Float 71,9%
More Financials
Company
Novozymes AS is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market are as follows: - domestic cleaning and servicing products industry (33.1%); - food industry (29%); - bioenergy (19.6%); - agriculture and animal feed industry (13.1%): enzymes used to improve the productivity and digestion of foods; - wastewater treatment and technical industry (5. 
Sector
Specialty Chemicals
Calendar
02/02Earnings Release
More about the company
Notations Surperformance© of Novozymes A/S
Trading Rating : Investor Rating :
More Ratings
All news about NOVOZYMES A/S
10:16aNOVOZYMES A/S : New enzyme helps producers of vital wheat gluten get more out of..
PU
01/08NOVOZYMES A/S : completes acquisition of Microbiome Labs
AQ
01/05NOVOZYMES A/S : New enzyme makes high protein drinks taste better
PU
2020NOVOZYMES A/S : acquires Microbiome Labs and adds a strong position in the North..
PU
2020NOVOZYMES A/S : acquires Microbiome Labs
AQ
2020NOVOZYMES A/S : switches to renewable electricity in North America
PU
2020NOVOZYMES A/S : New sales reporting structure introduced. 2020 organic sales gro..
AQ
2020NOVOZYMES A/S : New bioenergy enzyme solution harnesses the untapped potential o..
PU
2020NOVOZYMES A/S : New biological solution strengthens gluten and improves dough
PU
2020NOVOZYMES A/S : Proposal of candidates to the Board of Directors
AQ
2020NOVOZYMES A/S : Change of management
AQ
2020Givaudan Joins Novozymes to Discover New Sustainable Ingredients for Customer..
MT
2020NOVOZYMES A/S : Trading by management and close relations of management
AQ
2020NOVOZYMES A/S : Interim report for the first nine months of 2020
AQ
2020NOVOZYMES A/S : Nomination
CO
More news
News in other languages on NOVOZYMES A/S
01/25Apple, LVMH et Tesla au (copieux) menu de la semaine
01/25AVIS D'ANALYSTES DU JOUR : Aperam, ArcelorMittal, CD Projekt, Imerys, Leoni, Nov..
01/06Du rififi aux Etats-Unis pour l'Epiphanie
2020L'indice à suivre pour changer du Nasdaq
2020AVIS D'ANALYSTES DU JOUR : Adecco, Arkema, ASML, LafargeHolcim, Soltec, Superdry..
More news
Analyst Recommendations on NOVOZYMES A/S
More recommendations
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 19
Average target price 354,94 DKK
Last Close Price 376,60 DKK
Spread / Highest target 22,1%
Spread / Average Target -5,75%
Spread / Lowest Target -24,9%
EPS Revisions
Managers and Directors
NameTitle
Ester Baiget President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP
Lars Green Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S7.30%17 180
ECOLAB INC.-3.25%59 752
SIKA AG2.44%39 562
GIVAUDAN SA-0.08%38 759
EMS-CHEMIE HOLDING AG-1.47%22 152
SYMRISE AG-4.57%17 040